1Dalekos GN, Zachou K, Liaskos C, et al. Autoantibodies and defined target autoantigens in autoimmune hepatitis., an ovew. Eur J Intern Med, 2002, 13131:293-303.
2Pietro lnvernizzi, Ana IAeo, Mauro Podda. Interpreting serological test in diagnosing autoimmune liver diseases. Semin Liver Dis, 2007,27 : 161-172.
3Lyons R, Narain S, Nichols C, et al. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease. Ann NY Acad Sci, 2005, 1050:217-228.
4Gatselis NK, Georgiadou SP, Koukoulis GK, et al. Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C. Aliment Pharmacol Ther, 2006,24:1563-1573.
5Muratori P, Muratori L, Agostineui D, et al. Smooth muscle antibodies and type 1 antoimmune hepatitis. Autoimmunity, 2002,35:497-500.
6Christian F, Johannes H, Stefan L, et al. Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis. Am J Gastroenterol, 2006, 101 :2731-2736.
7Maria SL, Munther J, Hussain, et al. Cytochrome P450IID6- specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology, 2007,46:472-484.
8Muratori L, Granito A, Muratori P, et al. Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value. Clin Liver Dis, 2008, 12: 261- 276.
9Wies I, Brunner S, Henninger J, et al. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet, 2000,355 : 1510-1515.
10Zachou K, Rigopoulou E, Dalekos GN. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J Autoimmune Dis, 2004,1 : 2.
